Drug Catalog - Product Detail
CARTEOLOL HCL OPHTH. SOL. SOL 0.01 10ML
| NDC | Mfr | Size | Str | Form |
|---|---|---|---|---|
| 24208-0367-10 | BAUSCH HEALTH | 10 | 1% | SOLUTION |
Generic Name
Substance Name
Product Type
Route
Application Number
Description
DESCRIPTION Carteolol Hydrochloride Ophthalmic Solution USP, 1%, is a nonselective beta-adrenoceptor blocking agent for ophthalmic use. Carteolol hydrochloride is represented by the following structural formula: C 16 H 24 N 2 O 3 •HCl Mol. Wt. 328.84 Chemical Name: (±)-5-[3-[(1, 1-dimethylethyl) amino]-2-hydroxypropoxy]-3, 4-dihydro-2(1 H )-quinolinone monohydrochloride. Each mL of sterile solution contains: ACTIVE: Carteolol Hydrochloride 10 mg (1%), INACTIVES: Sodium Chloride, Monobasic and Dibasic Sodium Phosphate, Purified Water. PRESERVATIVE ADDED: Benzalkonium Chloride 0.005%. The product has a pH range of 6.2 - 7.2. Carteolol hydrochloride (structural formula)
How Supplied
HOW SUPPLIED Carteolol Hydrochloride Ophthalmic Solution USP, 1% is supplied as a sterile ophthalmic solution in a plastic bottle with a controlled drop tip in the following sizes: 5 mL bottles - NDC 24208-367-05 10 mL bottles - NDC 24208-367-10 15 mL bottles - NDC 24208-367-15
Indications & Usage
INDICATIONS AND USAGE Carteolol hydrochloride ophthalmic solution USP, 1%, has been shown to be effective in lowering intraocular pressure and may be used in patients with chronic open-angle glaucoma and intraocular hypertension. It may be used alone or in combination with other intraocular pressure lowering medications.
Dosage and Administration
DOSAGE AND ADMINISTRATION The usual dose is one drop of carteolol hydrochloride ophthalmic solution, 1%, in the affected eye(s) twice a day. If the patient’s IOP is not at a satisfactory level on this regimen, concomitant therapy with pilocarpine and other miotics, and/or epinephrine or dipivefrin, and/or systemically administered carbonic anhydrase inhibitors, such as acetazolamide, can be instituted.